Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology

Godbert, B.; Wissler, Marie-Pierre; Vignaud, Jean-Michel

doi:10.1183/09059180.00005812

Cited by 77 publications

(58 citation statements)

References 50 publications

(100 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, the pathologic pattern observed in CTD does not seem to affect the prognosis and survival as clearly as in the idiopathic setting. Although patients with idiopathic NSIP [20] or idiopathic desquamative interstitial pneumonia [21] have a dramatically better long-term survival than those with IPF [22][23][24], such a difference was not found in patients with systemic sclerosis or rheumatoid arthritis [3,10]. Studies correlating the pathological pattern with outcome all suffer the limitation of a high risk of constitutive selection bias, with lung biopsy being performed in individuals with the least typical pattern of disease at imaging.…”

Section: Does the Diagnosis Of Established Ctd Affect Prognosis Or Mamentioning

confidence: 99%

Significance of connective tissue diseases features in pulmonary fibrosis

Cottin

2013

European Respiratory Review

View full text Add to dashboard Cite

Interstitial lung disease (ILD) can occur in any of the connective tissue diseases (CTD) with varying frequency and severity, and an overall long-term prognosis that is less severe than that of idiopathic pulmonary fibrosis (IPF). Because ILD may be the presenting manifestation of CTD and/or the dominant manifestation of CTD, clinical extra-thoracic manifestations should be systematically considered in the diagnostic approach of ILD. When present, autoantibodies strongly contribute to the recognition and classification of the CTD. Patients with clinical extrathoracic manifestations of CTD and/or autoantibodies (especially with a high titer and/or the antibody is considered “highly specific” of an autoimmune condition), but who do not fit with established international CTD criteria may be called undifferentiated CTD or “lung-dominant CTD”. Although it remains to be determined which combination of symptoms and serologic tests best identify the subset of patients with clinically relevant CTD features, available evidence suggests that such patients may have distinct clinical and imaging presentation and may portend a distinct clinical course. However, autoantibodies alone when present in IPF patients do not seem to impact prognosis or management. Referral to a rheumatologist and multidisciplinary discussion may contribute to management of patients with undifferentiated CTD

show abstract

Section: Does the Diagnosis Of Established Ctd Affect Prognosis Or Mamentioning

confidence: 99%

Significance of connective tissue diseases features in pulmonary fibrosis

Cottin

2013

European Respiratory Review

View full text Add to dashboard Cite

show abstract

“…The typical pathological lesion of clusters of pigmented macrophages, which is observed in RBILD, is rarely seen in non-smokers. 4,5 The clinical presentation of this patient with predominant dyspnoea was compatible with a clinical diagnosis of interstitial lung disease.…”

Section: Discussionmentioning

confidence: 69%

Respiratory bronchiolitis associated interstitial lung disease (RB-ILD) in a non-smoking female

Siribaddana

2015

J of Cey Coll of Phy

View full text Add to dashboard Cite

“…Corticosteroid therapy may be used in conjunction with smoking cessation. This results in stabilisation or improvement in the majority of patients [21]. Residual GGO after treatment is common and may represent microscopic fibrosis as with respiratory bronchiolitis.…”

Section: Smoking-related Lung Diseasementioning

confidence: 99%

The role of high-resolution computed tomography in the follow-up of diffuse lung disease

2017

View full text Add to dashboard Cite

High-resolution computed tomography (HRCT) of the lung is a key component of the multidisciplinary approach to diagnosis in diffuse lung disease (DLD). HRCT also plays an important role in the follow-up of patients with established DLD. In this respect, serial HRCT examinations may provide valuable information that cannot be determined from clinical history and other diagnostic tests, such as pulmonary function tests. Important roles of HRCT in this context include assisting in determining prognosis, monitoring for the efficacy of treatment, detecting progression of disease or complications, and evaluating patients with worsening or acute symptoms. Both clinicians and radiologists should be aware of the expected evolution of HRCT changes in a variety of DLDs. The goals of this paper are to discuss: 1) the expected evolution of HRCT findings over time in common DLDs; 2) the role of serial HRCT examinations in formulating an initial diagnosis; and 3) the role of HRCT in the follow-up of patients with known DLD.

show abstract

Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology

Cited by 77 publications

References 50 publications

Significance of connective tissue diseases features in pulmonary fibrosis

Significance of connective tissue diseases features in pulmonary fibrosis

Respiratory bronchiolitis associated interstitial lung disease (RB-ILD) in a non-smoking female

The role of high-resolution computed tomography in the follow-up of diffuse lung disease

Contact Info

Product

Resources

About